Skip to content
POM-V Prescription Required Companion Animal

Meloxyl 1.5 mg/ml Oral Suspension for Dogs

Active ingredient: Meloxicam

Form

Liquid

Species

Dogs

Manufacturer

Chanelle Pharmaceuticals Manufacturing Ltd

VMD MA No.

08749/5155

What it's used for

Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders in dogs.

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Meloxicam

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Meloxyl 1.5 mg/ml Oral Suspension for Dogs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

Alleviation of inflammation and pain in both acute and chronic musculo-skeletal
disorders in dogs.
Shake well before use.
To be administered mixed with a small amount of food, or directly into the mouth.
Initial treatment is a single dose of 0.2 mg meloxicam/kg body weight on the first day.
Treatment is to be continued once daily by oral administration (at 24-hour intervals)
at a maintenance dose of 0.1 mg meloxicam/kg body weight. For longer term
treatment, once clinical response has been observed (after 4 days), the dose can
be adjusted to the lowest effective individual dose reflecting that the degree of pain
and inflammation associated with chronic musculo-skeletal disorders may vary over
time. Particular care should be taken with regard to the accuracy of dosing.
The suspension can be given using the Meloxicam measuring syringe provided in the
package. The syringe fits onto the bottle and has a kg-body weight scale which
corresponds to the maintenance dose (i.e. 0.1 mg meloxicam/kg body weight). Thus
for the first day, twice the maintenance volume will be required.
A clinical response is normally seen within 3–4 days. Treatment should be
discontinued after 10 days at the latest if no clinical improvement is apparent.
Do not use in pregnant or lactating animals.
Do not use in animals suffering from gastrointestinal disorders such as irritation and
haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic
disorders.
Do not use in case of hypersensitivity to the active substance or to any of the
excipients.
Do not use in dogs less than 6 weeks of age.
Typical adverse reactions of NSAIDs such as loss of appetite, vomiting, diarrhoea,
faecal occult blood, lethargy and renal failure have occasionally been reported. In
very rare cases haemorrhagic diarrhoea, haematemesis, gastrointestinal ulceration
and elevated liver enzymes have been reported. These side effects occur generally
within the first treatment week and are in most cases transient and disappear
following termination of the treatment but in very rare cases may be serious or fatal.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports)
If adverse reactions occur, treatment should be discontinued and the advice of a
veterinarian should be sought.
None.

Revised: October 2025
AN: 02176/2025

Special precautions for use in animals
Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a
potential risk of increased renal toxicity.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals.
People with known hypersensitivity to non-steroidal anti-inflammatory drugs
(NSAIDs) should avoid contact with the veterinary medicinal product.
Any uneaten medicated food must be disposed of immediately and the bowl washed
thoroughly.
Do not leave an unattended filled syringe in the sight or reach of children.
In case of accidental ingestion, seek medical advice immediately and show the
package leaflet or the label to the physician.
Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics and substances
with high protein binding may compete for binding and thus lead to toxic effects.
Meloxicam must not be administered in conjunction with other NSAIDs or
glucocorticosteroids.
Pre-treatment with anti-inflammatory substances may result in additional or increased
adverse effects and accordingly a treatment-free period with such veterinary
medicinal products should be observed for at least 24 hours before commencement
of treatment. The treatment-free period, however, should take into account the
pharmacological properties of the veterinary products used previously.

Revised: October 2025
AN: 02176/2025
This veterinary medicinal product does not require any special storage conditions.
Not applicable.
5.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.